Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2018

31.05.2018 | Original Article

Colorectal Polyps in Childhood Cancer Survivors Treated with Radiation Therapy

verfasst von: Sammy Au, Vladimir Marquez, Fergal Donnellan, Baljinder S. Salh, Michael Nimmo, Karen J. Goddard, Majid Alsahafi, Nazira Chatur

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Cancer survivors treated with abdominal or pelvic radiation therapy (RT) for childhood cancer have an increased risk of colorectal cancer. However, clinical guidelines are inconsistent on recommendations regarding the early initiation of screening in these patients due to the lack of supporting evidence that these patients pass through a pre-invasive phase, in which adenomatous polyps can be detected and removed.

Aims

To determine the prevalence of adenomatous polyps in cancer survivors treated with RT for childhood cancer; the prevalence in average-risk patients aged 17–49; and the prevalence in average-risk patients aged 50–75.

Methods

We conducted a retrospective study comparing the prevalence of adenomatous polyps among three patient groups: childhood cancer survivors aged 17–49 with prior RT who underwent colonoscopy screening from 2006 to 2017; age- and gender-matched patients in the average-risk population; and average-risk patients aged 50–75.

Results

One hundred and forty-five patients were included in the study. The proportion of patients with adenomatous polyps in the cancer survivor group was significantly higher than that in the age- and gender-matched average-risk group (58.6 vs 17.2%, p = 0.00) and higher than the average-risk group aged 50–75 (58.6 vs 27.6%, p = 0.009). The prevalence of adenomas with high-risk features was higher in the survivor group compared to patients aged 50–75 (20.7 vs 3.5%, p = 0.015).

Conclusions

Cancer survivors treated with RT for childhood cancer have a higher prevalence of adenomatous polyps compared to the average-risk population. These findings support the early initiation of colonoscopy screening 10 years after radiation therapy, even in patients who have received RT doses below 30 Gy.
Literatur
1.
Zurück zum Zitat Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA.. 2011;305:2311–2319.CrossRefPubMed Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA.. 2011;305:2311–2319.CrossRefPubMed
2.
Zurück zum Zitat Teepen JC, de Vroom SL, van Leeuwen FE, et al. Risk of subsequent gastrointestinal cancer among childhood cancer survivors: A systematic review. Cancer Treat Rev. 2016;43:92–103.CrossRefPubMed Teepen JC, de Vroom SL, van Leeuwen FE, et al. Risk of subsequent gastrointestinal cancer among childhood cancer survivors: A systematic review. Cancer Treat Rev. 2016;43:92–103.CrossRefPubMed
3.
Zurück zum Zitat Nottage K, McFarlane J, Krasin MJ, et al. Secondary colorectal carcinoma after childhood cancer. J Clin Oncol. 2012;30:2552–2558.CrossRefPubMed Nottage K, McFarlane J, Krasin MJ, et al. Secondary colorectal carcinoma after childhood cancer. J Clin Oncol. 2012;30:2552–2558.CrossRefPubMed
4.
Zurück zum Zitat Henderson TO, Oeffinger KC, Whitton J, et al. Secondary gastrointestinal cancer in childhood cancer survivors: A cohort study. Ann Intern Med. 2012;156:757–766, W-260. Henderson TO, Oeffinger KC, Whitton J, et al. Secondary gastrointestinal cancer in childhood cancer survivors: A cohort study. Ann Intern Med. 2012;156:757–766, W-260.
5.
Zurück zum Zitat Schaapveld M, Aleman BM, van Eggermond AM, et al. Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma. N Engl J Med. 2015;373:2499–2511.CrossRefPubMed Schaapveld M, Aleman BM, van Eggermond AM, et al. Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma. N Engl J Med. 2015;373:2499–2511.CrossRefPubMed
6.
Zurück zum Zitat Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476–483.CrossRefPubMed Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476–483.CrossRefPubMed
7.
Zurück zum Zitat Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: The childhood cancer survivor study. J Natl Cancer Inst. 2010;102:1083–1095.CrossRefPubMedPubMedCentral Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: The childhood cancer survivor study. J Natl Cancer Inst. 2010;102:1083–1095.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973–2002. Int J Cancer. 2007;121:2233–2240.CrossRefPubMed Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973–2002. Int J Cancer. 2007;121:2233–2240.CrossRefPubMed
9.
Zurück zum Zitat Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin’s lymphoma. J Clin Oncol. 2007;25:1489–1497.CrossRefPubMed Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin’s lymphoma. J Clin Oncol. 2007;25:1489–1497.CrossRefPubMed
10.
Zurück zum Zitat Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin’s disease: A population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484–3494.CrossRefPubMed Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin’s disease: A population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484–3494.CrossRefPubMed
11.
Zurück zum Zitat Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: Report from the Late Effects Study Group. J Clin Oncol.. 2003;21:4386–4394.CrossRefPubMed Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: Report from the Late Effects Study Group. J Clin Oncol.. 2003;21:4386–4394.CrossRefPubMed
12.
Zurück zum Zitat van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487–497.CrossRefPubMed van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487–497.CrossRefPubMed
13.
Zurück zum Zitat Strul H, Kariv R, Leshno M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–262.CrossRefPubMed Strul H, Kariv R, Leshno M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–262.CrossRefPubMed
15.
Zurück zum Zitat Muller A, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-controlled study of 32,702 veterans. Ann Intern Med. 1995;123:904–910.CrossRefPubMed Muller A, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-controlled study of 32,702 veterans. Ann Intern Med. 1995;123:904–910.CrossRefPubMed
16.
Zurück zum Zitat Brenner H, Chang-Claude J, Jansen L, et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterol. 2014;146:709–717.CrossRef Brenner H, Chang-Claude J, Jansen L, et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterol. 2014;146:709–717.CrossRef
17.
Zurück zum Zitat Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.CrossRefPubMedPubMedCentral Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer. Volume version 4, 2013. Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer. Volume version 4, 2013.
19.
Zurück zum Zitat Daly PE, Samiee S, Cino M, et al. High prevalence of adenomatous colorectal polyps in young cancer survivors treated with abdominal radiation therapy: Results of a prospective trial. Gut.. 2017;66:1797–1801.CrossRefPubMed Daly PE, Samiee S, Cino M, et al. High prevalence of adenomatous colorectal polyps in young cancer survivors treated with abdominal radiation therapy: Results of a prospective trial. Gut.. 2017;66:1797–1801.CrossRefPubMed
20.
Zurück zum Zitat Glockenberg KS, Shah P, Shike M, et al. Colon adenoma and carcinoma among adult survivors of childhood and young adult cancer. J Gastroenterol Hepatol. 2017;6:2425–2429.CrossRef Glockenberg KS, Shah P, Shike M, et al. Colon adenoma and carcinoma among adult survivors of childhood and young adult cancer. J Gastroenterol Hepatol. 2017;6:2425–2429.CrossRef
Metadaten
Titel
Colorectal Polyps in Childhood Cancer Survivors Treated with Radiation Therapy
verfasst von
Sammy Au
Vladimir Marquez
Fergal Donnellan
Baljinder S. Salh
Michael Nimmo
Karen J. Goddard
Majid Alsahafi
Nazira Chatur
Publikationsdatum
31.05.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5138-9

Weitere Artikel der Ausgabe 9/2018

Digestive Diseases and Sciences 9/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.